[Form 4] IMAX CORP Insider Trading Activity

Rhea-AI Filing Summary

IMAX Corporation’s Chief Financial Officer and EVP, Natasha Fernandes, reported an options exercise and share sale involving the company’s common shares. On 11/24/2025, she exercised 2,652 stock options with an exercise price of $22.49 per share, converting them into 2,652 common shares. That same day, she sold 2,652 common shares at an average price of $36.1479 per share, returning her directly held common share balance to 31,257 shares.

The options were originally granted in 2019 and are scheduled to expire on March 7, 2026, having vested in four annual installments between 2020 and 2023. Following these transactions, Ms. Fernandes’ aggregate remaining outstanding restricted share unit balance is 39,734, and her common share balance remains 31,257, reflecting a same-day exercise-and-sale transaction structure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fernandes Natasha

(Last) (First) (Middle)

2525 SPEAKMAN DRIVE

(Street)

MISSISSAUGA A6 L5K1B1

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer & EVP

3. Date of Earliest Transaction (Month/Day/Year)
11/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
common shares (opening balance)								31,257	D
common shares	11/24/2025		C		2,652(1)	A	$22.49	33,909	D
common shares	11/24/2025		S		2,652	D	$36.1479	31,257	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock options (to buy)(2)	$22.49	11/24/2025		C			2,652	(3)	03/07/2026	common shares	2,652	$22.49	0(4)	D

Explanation of Responses:

1. Represents the conversion upon exercise of stock options into common shares.

2. These options were issued in 2019 and are set to expire on March 7, 2026.

3. The stock options became exercisable in four installments: 530 on March 7, 2020, 663 on each of March 7, 2021 and March 7, 2022 and 796 on March 7, 2023.

4. This represents the number of stock options for this transaction only. Ms. Fernandes' aggregate remaining outstanding restricted share unit and common share balances following these transactions will be 39,734 and 31,257, respectively.

Remarks:

	/s/Kenneth I. Weissman (attorney-in-fact for Natasha Fernandes)	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did IMAX (IMAX) report for its CFO on 11/24/2025?

On 11/24/2025, IMAX Chief Financial Officer and EVP Natasha Fernandes exercised 2,652 stock options at $22.49 per share and sold 2,652 common shares at an average price of $36.1479 per share.

How many IMAX (IMAX) shares does the CFO hold after the reported transactions?

After the reported transactions, Natasha Fernandes beneficially owns 31,257 common shares, and her remaining outstanding restricted share unit balance is 39,734.

What were the details of the IMAX (IMAX) stock options exercised by the CFO?

The CFO exercised 2,652 stock options with an exercise price of $22.49 per share. These options were issued in 2019, became exercisable in four annual installments from 2020 to 2023, and are set to expire on March 7, 2026.

Did the IMAX (IMAX) CFO’s total share count change as a result of the Form 4 transactions?

The CFO’s directly held common share balance ended at 31,257 shares, the same level noted as her balance following the reported transactions, reflecting a same-day exercise and sale.

What is the role of the reporting person in IMAX (IMAX)?

The reporting person, Natasha Fernandes, is identified as an Officer of IMAX Corporation, serving as Chief Financial Officer & EVP.

Were the IMAX (IMAX) transactions reported as direct or indirect ownership?

The common shares reported, including the 31,257 shares beneficially owned after the transactions, are shown as held under direct (D) ownership.